Brn-2 represses microphthalmia-associated transcription factor expression and marks a distinct subpopulation of microphthalmia-associated transcription factor-negative melanoma cells.
The origin of tumor heterogeneity is poorly understood, yet it represents a major barrier to effective therapy. In melanoma and in melanocyte development, the microphthalmia-associated transcription factor (Mitf) controls survival, differentiation, proliferation, and migration/metastasis. The Brn-2...
主要な著者: | Goodall, J, Carreira, S, Denat, L, Kobi, D, Davidson, I, Nuciforo, P, Sturm, R, Larue, L, Goding, C |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2008
|
類似資料
-
The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes.
著者:: Carreira, S, 等
出版事項: (2000) -
The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression.
著者:: Schepsky, A, 等
出版事項: (2006) -
CBP/p300 as a co-factor for the Microphthalmia transcription factor.
著者:: Sato, S, 等
出版事項: (1997) -
The Brn-2 transcription factor links activated BRAF to melanoma proliferation.
著者:: Goodall, J, 等
出版事項: (2004) -
The role of the transcription factor BRN2 in melanoma
著者:: Herbert, K
出版事項: (2018)